Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention

Although the new oral P2Y(12) inhibitors, prasugrel/ticagrelor have shown greater efficacy than clopidogrel in patients with the acute coronary syndrome, but they have not shown better efficacy in Korean patients. So we evaluated the efficacy of the prasugrel/ticagrelor in patients with myocardial i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Kye Taek, Seong, Seok-Woo, Choi, Ung Lim, Jin, Seon-Ah, Kim, Jun Hyung, Lee, Jae-Hwan, Choi, Si Wan, Jeong, Myung Ho, Chae, Shung Chull, Kim, Young Jo, Kim, Chong Jin, Kim, Hyo-Soo, Cho, Myeong-Chan, Gwon, Hyeon-Cheol, Jeong, Jin-Ok, Seong, In-Whan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426627/
https://www.ncbi.nlm.nih.gov/pubmed/30882670
http://dx.doi.org/10.1097/MD.0000000000014833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426627/
https://www.ncbi.nlm.nih.gov/pubmed/30882670
http://dx.doi.org/10.1097/MD.0000000000014833

Ejemplares similares